These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21531455)

  • 21. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
    Mohs AM; Wang X; Goodrich KC; Zong Y; Parker DL; Lu ZR
    Bioconjug Chem; 2004; 15(6):1424-30. PubMed ID: 15546211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
    Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes.
    Luo K; Liu G; He B; Wu Y; Gong Q; Song B; Ai H; Gu Z
    Biomaterials; 2011 Apr; 32(10):2575-85. PubMed ID: 21256587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benchtop-MRI for in vivo imaging using a macromolecular contrast agent based on hydroxyethyl starch (HES).
    Besheer A; Caysa H; Metz H; Mueller T; Kressler J; Mäder K
    Int J Pharm; 2011 Sep; 417(1-2):196-203. PubMed ID: 21056646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.
    Veiseh M; Gabikian P; Bahrami SB; Veiseh O; Zhang M; Hackman RC; Ravanpay AC; Stroud MR; Kusuma Y; Hansen SJ; Kwok D; Munoz NM; Sze RW; Grady WM; Greenberg NM; Ellenbogen RG; Olson JM
    Cancer Res; 2007 Jul; 67(14):6882-8. PubMed ID: 17638899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.
    Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
    J Control Release; 2012 Aug; 162(1):111-8. PubMed ID: 22709587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure.
    Kobayashi H; Jo SK; Kawamoto S; Yasuda H; Hu X; Knopp MV; Brechbiel MW; Choyke PL; Star RA
    J Magn Reson Imaging; 2004 Sep; 20(3):512-8. PubMed ID: 15332261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase.
    Kobayashi H; Kawamoto S; Star RA; Waldmann TA; Brechbiel MW; Choyke PL
    Bioconjug Chem; 2003; 14(5):1044-7. PubMed ID: 13129410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo magnetic resonance imaging with chlorotoxin-conjugated superparamagnetic nanoprobes for targeting hepatocarcinoma.
    Chen Z; Xiao EH; Kang Z; Zeng WB; Tan HL; Li HB; Bian DJ; Shang QL
    Oncol Rep; 2016 May; 35(5):3059-67. PubMed ID: 26934940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.
    Xu R; Wang Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1081-9. PubMed ID: 17720954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas.
    Zhao L; Zhu J; Cheng Y; Xiong Z; Tang Y; Guo L; Shi X; Zhao J
    ACS Appl Mater Interfaces; 2015 Sep; 7(35):19798-808. PubMed ID: 26291070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging.
    Ye M; Qian Y; Tang J; Hu H; Sui M; Shen Y
    J Control Release; 2013 Aug; 169(3):239-45. PubMed ID: 23403397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionalized magnetic nanochains with enhanced MR imaging: A novel nanosystem for targeting and inhibition of early glioma.
    Zhang Y; Huang Z; Wu Z; Yin G; Wang L; Gao F
    Colloids Surf B Biointerfaces; 2016 Apr; 140():437-445. PubMed ID: 26803007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gd3+-DTPA-bis (N-methylamine) - anionic linear globular Dendrimer-G1; a more efficient MRI contrast media.
    Ghalandarlaki N; Mohammadi TD; Agha Babaei R; Tabasi MA; Keyhanvar P; Mehravi B; Yaghmaei P; Cohan RA; Ardestani MS
    Drug Res (Stuttg); 2014 Feb; 64(2):57-65. PubMed ID: 24310361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimethyl sulfoxide (DMSO) as a potential contrast agent for brain tumors.
    Delgado-Goñi T; Martín-Sitjar J; Simões RV; Acosta M; Lope-Piedrafita S; Arús C
    NMR Biomed; 2013 Feb; 26(2):173-84. PubMed ID: 22814967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.